Articles Tagged With:
-
Rocky Mountain Spotted Fever: California and Mexico
The Centers for Disease Control and Prevention alerts clinicians to cases of Rocky Mountain spotted fever in southern California that had been acquired in Mexico.
-
Comparing Adjuvant Clindamycin to Linezolid for Invasive Group A Streptococcal Infections
In a retrospective, single-center cohort study of patients with severe group A streptococcal infection, there was no significant difference in clinical response in those treated with adjunctive clindamycin as compared with adjunctive linezolid
-
Imported Gestational Malaria
Pregnant women can develop malaria in non-endemic areas, even when they are far removed from malaria exposure both geographically and temporally.
-
ID Consultation Leads to Reduced Mortality from Gram-Negative Bacteremia
A multicenter, retrospective cohort study on patients with gram-negative bacteremia found infectious diseases consultation was associated with a 40% decrease in 30-day mortality.
-
2024 Resolution: Not to Be Replaced by a Machine
Chatbots, such as ChatGPT, are thought to have potential to eventually replace some straightforward infectious disease consultations. However, current technology does not yet instill confidence that the use of chatbots will be adequately accurate or safe for complex patient care. In addition, philosophical and ethical constraints raise doubt about the value of replacing specialist physician consultations.
-
Vonoprazan Fumarate Tablets (Voquezna)
The U.S. Food and Drug Administration has approved vonoprazan for the treatment of all grades of erosive esophagitis. Vonoprazan is a potassium-competitive acid blocker that originally was approved in 2022 for use in combination with amoxicillin or with amoxicillin and clarithromycin for the treatment of Helicobactor pylori infection.
-
Calling ED Boarding a Public Health Crisis, ACEP Pushes Policymakers to Act
Too many EDs are bursting at the seams with patients who have been admitted but languish in the emergency setting for hours, days, or even weeks before they are moved to an inpatient bed. That is the message the American College of Emergency of Physicians is urgently sending to policymakers, saying the situation with ED boarding has become a public health crisis.
-
Treatable Causes of Rapidly Progressive Dementias
Many cases of rapidly progressive dementia are caused by prion diseases and have no effective treatments. But, with the greater awareness of the presentation for autoimmune encephalitis, these disorders make up an increasing percentage of presenting cases and can be aggressively and successfully treated. The STAM3P score helps to identify potentially treatable cases of this disorder.
-
Pediatric Burn Care: Strategies for Identification and Treatment
Pediatric burn injuries, especially minor, are an essential part of caring for children. Classification of the depth of injury, recognition of nonaccidental trauma, and appropriate care are all critical aspects of management. The authors comprehensively review pediatric burn care.
-
Apixaban Dose in Atrial Fibrillation Patients with Chronic Kidney Disease
A large nationwide health systems database study comparing 5 mg apixaban vs. 2.5 mg twice daily in patients with stage 4/5 chronic kidney disease not on dialysis shows that the 5 mg dose increases the risk of bleeding compared to 2.5 mg without any improvement in the risk of stroke, systemic emboli, or death.